7Carey I, Harrison PM. Monotherapy versus combination therapy for the treatment of chronic hepatitis B. Expert Opin Investig Drugs, 2009, 18( 11 ) : 1655-1666.
8Terrault NA. Benefits and risks of combination therapy for hepatitis B. Hepatology, 2009, 49(5 Supp|) : S122-128.
9Tseng PL, Lu SN, Tung HD, et al?Determinants of earlymortality and benefits of lamivudine therapy in patientswith hepatitis B virus-related decompensated livercirrhosis[J]. J Viral Hepat ,2005 ?12(4) :386 - 392.
10Chen G, Lin W, Shen F, et al. Past HBV viral load aspredictor of mortality and morbidity from HCC andchronic liver disease in a prospective study [J]. Am JGastroenterol ?2006,101(8) : 1797 - 1803.
